A dilemma in analysis: Issues in the serial measurement of quality of life in patients with advanced lung cancer

Lung Cancer

Volumn 18, Issue 2, 1997, Pages 119-136

  Hollen, Patricia J ^a   Gralla, Richard J ^b   Cox, Christopher ^c   Eberly, Shirley W ^c   Kris, Mark G ^d  

^a NORTHEASTERN UNIVERSITY   (United States)

^b Ochsner Cancer Institute   (United States)

^c UNIVERSITY OF ROCHESTER   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Lung cancer; Lung Cancer Symptom Scale; Quality of life analysis

Indexed keywords

ADULT; ADVANCED CANCER; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER STAGING; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; STATISTICAL ANALYSIS;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MORTALITY; PROSPECTIVE STUDIES; QUALITY OF LIFE;

EID: 0030952652     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(97)00059-7     Document Type: Article

References (26)

1. Outcomes Working Group, Health Services Research Committee, American Society of Clinical Oncology. Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. J Clin Oncol 1996;14:671-9.
2. Fayers PM, Jones DR. Measuring and analysing quality of life in cancer clinical trials: a review. Stat Med 1983;2:429-46.
3. Pocock SJ. Clinical Trials: A Practical Approach. New York: Wiley, 1983.
4. Fletcher AE. Measurement of quality of life in clinical trials of therapy. In: Scheurlen H, Kay R, Baum M, editors. Cancer Clinical Trials: A Critical Appraisal, Recent Results in Cancer Research, vol. 3. Berlin: Springer, 1988:216-230.
5. Campbell DT, Stanley JC. Experimental and Quasi-experimental Designs for Research. Boston: Houghton Mifflin, 1963.
6. Burke MT, Gralla R, Kris M, et al. Subjective evaluation in non-small cell lung cancer: comparison of Karnofsky performance status with a patient generated visual analogue scale measuring activity. Proceedings of the Fourth World Conference on Lung Cancer 1985;4:42.
7. Monras P, Gralla RJ, Burke MT, et al. Development of specific instruments for subjective evaluation of patients with lung cancer: comparison of observer assessment with patient generated visual analogue scales (VAS). Proc Am Soc Clin Oncol 1985;4:251.
8. Hollen PJ, Gralla RJ, Kris MG, Potanovich LM. Quality of life assessment in individuals with lung cancer: testing the Lung Cancer Symptom Scale (LCSS). Eur J Cancer 1993;29A:S51-8.
9. Hollen PJ, Gralla RJ, Kris MG, et al. Measurement of quality of life in patients with lung cancer in multicenter trials of new therapies: psychometric assessment of the Lung Cancer Symptom Scale. Cancer 1994;73:2087-98.
10. Hollen PJ, Gralla RJ, Kris MG, Cox C. Quality of life during clinical trials: conceptual model for the Lung Cancer Symptom Scale (LCSS). Support Care Cancer 1994;2:213-22.
11. Kraemer HC, Thiemann S. A strategy to use soft data effectively in randomized controlled clinical trials. J Consult Clin Psychol 1989;57(1):148-54.
12. Hollen PJ, Gralla RJ, Cox C, Eberly SW. A dilemma in analysis: measurement issues in the longitudinal analysis of quality of life in 673 patients with advanced lung cancer. Proc Am Soc Clin Oncol 1994;13:329.
13. Comis R, Kris MG, Lee JS, et al. Multicenter, randomized trials in 673 comparing the combination of edatrexate, mitomycin, and vinblastine (EMV) with mitomycin and vinblastine (MV) in patients with Stage III and IV non-small cell lung cancer. Lung Cancer 1994;11:119.
14. Gralla RJ, Lee JS, Kris MG, et al. Multicenter, randomized trials comparing the combination of edatrexate, mitomycin and vinblastine (EMV) with mitocycin and vinblastine (MV) in 673 patients with Stage III and IV non-small cell lung cancer. Proc Am Soc Clin Oncol 1994;13:347.
15. Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM, editor. Evaluation of Chemotherapeutic Agents. Symposium, Microbiology Section, New York Academy of Medicine. New York: Columbia University Press, 1949:191-205.
16. Hettmansperger TP. Statistical Inference Based on Ranks. Malabar, FL: Krieger, 2nd ed. 1991.
17. Smith ND. Quality of life studies from the perspective of an FDA reviewing statistician. Drug Inf J 1993;27:617-23.
18. Zee B, Pater J. Statistical analysis of trials assessing quality of life. In: Osoba D, editor. Effect of Cancer on Quality of Life. Boca Raton, FL: CRC Press, 1991:113-124.
19. Simon R, Wittes RE. Methodologic guidelines for reports of clinical trials. Cancer Treat Rep. 1 1985;69:1-3.
20. Presant CA, Wiseman C, Blayney D, et al. Proposed criteria for serial evaluation of quality of life in cancer patients. J Natl Cancer Inst 1990;82:322-3.
21. Nayfield SG, Ganz PA, Moinpour CM, et al. Report from a National Cancer Institute (USA) workshop on quality of life assessment in cancer clinical trials. Qual Life Res 1992;1:203-10.
22. Searle SR, Casella G, McCulloch CE. Variance Components. New York: Wiley, 1992.
23. Little JM. A method of calculating the value of palliative care of cancer patients. Aust New Zealand J Surg 1987;57:393-7.
24. Orenstein DM, Kaplan RM. Measuring the quality of well-being in cystic fibrosis and lung transplantation: the importance of the area under the curve. Chest 1991;100:1016-8.
25. Hollen PJ, Gralla RJ. Comparison of instruments for measuring quality of life in patients with lung cancer. Semin Oncol 1996;23(Suppl 5):31-40.
26. Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Br Med J 1995;311:899-909.